H.R. 1706, the Protecting Consumer Access to Generic Drugs Act of 2009 : hearing before the Subcommittee on Commerce, Trade, and Consumer Protection of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, first session, March 31 2009.
| Corporate Author: | United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Commerce, Trade, and Consumer Protection |
|---|---|
| Format: | Government Document eBook |
| Language: | English |
| Published: |
Washington :
U.S. G.P.O.,
2012.
|
| Subjects: | |
| Online Access: | https://purl.fdlp.gov/GPO/gpo20996 |
Similar Items
Protecting Consumer Access to Generic Drugs Act of 2007 : hearing before the Subcommittee on Commerce, Trade, and Consumer Protection of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, on H.R. 1902, May 2, 2007.
Published: (2007)
Published: (2007)
Protecting Consumer Access to Generic Drugs Act of 2007 : hearing before the Subcommittee on Commerce, Trade, and Consumer Protection of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, on H.R. 1902, May 2, 2007.
Published: (2007)
Published: (2007)
H.R. 1706, the Protecting Consumer Access to Generic Drugs Act of 2009 : hearing before the Subcommittee on Commerce, Trade, and Consumer Protection of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, first session, March 31 2009.
Published: (2012)
Published: (2012)
Protecting Consumer Access to Generic Drugs Act of 2019 : report (to accompany H.R. 1499) (including cost estimate of the Congressional Budget Office).
Published: (2019)
Published: (2019)
Generic drugs : stakeholders views on improving FDA's information on patents : report to congressional committees /
Published: (2023)
Published: (2023)
Generic drug entry prior to patent expiration : an FTC study /
Published: (2002)
Published: (2002)
Increasing generic drug utilization : saving money for patients : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Ninth Congress, first session, May 18, 2005.
Published: (2005)
Published: (2005)
Expanding the use of generic drugs.
Published: (2010)
Published: (2010)
The effect of generic drug competition on generic drug prices during the Hatch-Waxman 180-day exclusivity period /
by: Olson, Luke M., et al.
Published: (2013)
by: Olson, Luke M., et al.
Published: (2013)
Generic drugs : saving money at the pharmacy.
Published: (1998)
Published: (1998)
Authorized generic drugs : short-term effects and long-term impact.
Published: (2011)
Published: (2011)
Facts about generic drugs.
Published: (2006)
Published: (2006)
Generic drug product development : solid oral dosage forms /
Published: (2005)
Published: (2005)
Increasing generic drug utilization : saving money for patients : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Ninth Congress, first session, May 18, 2005.
Published: (2005)
Published: (2005)
FDA's generic drug approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session.
Published: (1989)
Published: (1989)
Generic drug product development : bioequivalence issues /
Published: (2008)
Published: (2008)
Generic drugs : saving money at the pharmacy /
Published: (1998)
Published: (1998)
FDA's generic drug application policy : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundredth Congress, second session, July 28, 1988.
Published: (1989)
Published: (1989)
Generic substitution and prescription drug prices : economic effects of state drug product selection laws /
by: Masson, Alison, et al.
Published: (1985)
by: Masson, Alison, et al.
Published: (1985)
"Skinny labels" for generic drugs under Hatch-Waxman /
by: Hickey, Kevin J.
Published: (2024)
by: Hickey, Kevin J.
Published: (2024)
Examining concerns regarding FDA's proposed changes to generic drug labeling : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 1, 2014.
Published: (2016)
Published: (2016)
Generic drug laws : a decade of trial, a prescription for progress /
Published: (1986)
Published: (1986)
Authorized generics : an interim report.
Published: (2009)
Published: (2009)
Generic drug user fee amendments : accelerating patient access to generic drugs : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session ... January 28, 2016.
Published: (2018)
Published: (2018)
Generic drug enforcement : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, on H.R. 2454 ... June 26, 1991.
Published: (1991)
Published: (1991)
Generic Animal Drug and Patent Term Restoration Act : hearing before the Subcommittee on Courts, Civil Liberties, and the Administration of Justice of the Committee on the Judiciary, House of Representatives, One Hundredth Congress, second session on H.R. 4982 ... September 14, 1988.
Published: (1989)
Published: (1989)
The marketing of generic drugs : a guide to counter-strategies for the technology intensive pharmaceutical companies /
by: James, Barrie G.
Published: (1981)
by: James, Barrie G.
Published: (1981)
Entry threats and pricing in the generic drug industry /
by: Wendling, Brett
Published: (2010)
by: Wendling, Brett
Published: (2010)
Retrosynthesis in the manufacture of generic drugs : selected case studies /
by: Santos, Pedro Paulo, et al.
Published: (2021)
by: Santos, Pedro Paulo, et al.
Published: (2021)
FDA's generic drug approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session.
Published: (1989)
Published: (1989)
Examining issues related to competition in the pharmaceutical marketplace : a review of the FTC report, Generic drug entry prior to patent expiration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, October 9, 2002.
Published: (2002)
Published: (2002)
Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 9, 2012.
Published: (2013)
Published: (2013)
Generic pharmaceuticals : marketplace access and consumer issues : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Seventh Congress, second session, April 23, 2002.
Published: (2004)
Published: (2004)
Generic pharmaceuticals : marketplace access and consumer issues : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Seventh Congress, second session, April 23, 2002.
Published: (2004)
Published: (2004)
Trends in brand name and generic prescribed medicine utilization and expenditures, 1999 to 2003 /
by: Stagnitti, Marie N.
Published: (2006)
by: Stagnitti, Marie N.
Published: (2006)
Drug pricing : research on savings from generic drug use /
by: Dicken, John E.
Published: (2012)
by: Dicken, John E.
Published: (2012)
Prescription drugs : implications of drug labeling and off-label use : statement of Sarah F. Jagger, Director of Health Services Quality and Public Health Issues, Health, Education, and Human Services Division, before the Subcommittee on Human Resources and Intergovernmental Relations, Committee on Government Reform and Oversight, U.S. House of Representatives /
by: Jagger, Sarah F.
Published: (1996)
by: Jagger, Sarah F.
Published: (1996)
Committee prints on administration legislative proposals on the Animal Drug User Fee Act Amendments of 2008 and the Animal Generic Drug User Fee Act of 2008 : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, June 5, 2008.
Published: (2008)
Published: (2008)
Why are some generic drugs skyrocketing in price? : hearing before the Subcommittee on Primary Health and Aging of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Thirteenth Congress, second session, on examining the pricing of generic drugs, November 20, 2014.
Published: (2017)
Published: (2017)
Rx for generic drug safety : accurate information for older Americans : hearing before the Subcommittee on Housing and Consumer Interests of the Select Committee on Aging, House of Representatives, One Hundred First Congress, second session, March 1, 1990.
Published: (1990)
Published: (1990)